CCHT(SZ:000661) Xin Lang Cai Jing·2025-09-18 05:46Group 1 - The core viewpoint of the news is that Changchun High-tech has seen a significant increase in its stock price, rising by 5.18% to 130.30 CNY per share, with a trading volume of 1.527 billion CNY and a turnover rate of 3.00%, resulting in a total market capitalization of 53.154 billion CNY [1] - Changchun High-tech is primarily engaged in the research, production, and sales of biopharmaceuticals and traditional Chinese medicine, with 92.83% of its revenue coming from the pharmaceutical sector, 6.81% from real estate, and 0.36% from services [1] - The company was established on June 10, 1993, and was listed on December 18, 1996, indicating a long-standing presence in the market [1] Group 2 - Among the top ten circulating shareholders of Changchun High-tech, Huatai-PB Fund's Huatai-PB CSI 300 ETF (510300) increased its holdings by 731,600 shares in the second quarter, bringing its total to 5.7621 million shares, which accounts for 1.44% of the circulating shares [2] - The estimated floating profit from this investment is approximately 36.9927 million CNY [2] - The Huatai-PB CSI 300 ETF has a total scale of 374.704 billion CNY and has achieved a year-to-date return of 18.19%, ranking 2916 out of 4222 in its category [2]